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Thyroid hormones, 3,5,3’5’-tetraiodothyronine (thyrox-
ine) and 3,5,3’-triiodothyronine (T3) contribute to the
regulation of key cellular processes, including prolifera-
tion, differentiation, apoptosis and metabolism. Thus,
deregulation of thyroid hormone pathway can result in
serious disturbances of cellular physiology such as those
observed in tumoral transformation. The intra- and
extracellular concentrations of thyroid hormones (TH)
are regulated by three types of iodothyronine deiodinases
(DIO1, DIO2, and DIO3). These enzymes catalyze two
types of reactions: deiodination in position 5’ of iodothyr-
onines (catalyzed by DIO1 and DIO2), resulting in activa-
tion of thyroid hormones, and deiodination in position 5
of iodothyronines (catalyzed by DIO1 and DIO3), which
results in inactivation of thyroid hormones. Changes in
expression and activity of iodothyronine deiodinases
result in modulations of thyroid hormone concentrations
and thus influence cellular processes. The actions of thyr-
oid hormone are mediated by thyroid hormone receptors
(TRs) which influence intracellular processes via modula-
tion of expression of target genes. In this process, known
as genomic mechanism of TH action, thyroid hormone
receptors act as transcription factors whose activity is
modulated by the presence of ligand, T3. TH can also
influence cellular processes via non-genomic pathways in
which TH modulate activity of membrane or intracellular
receptors and activate different intracellular signaling
pathways, involving protein kinases, for instance PI3K,
and Akt/PKB.
In the process of carcinogenesis the signaling pathway
of thyroid hormones is disturbed. This is illustrated by
observations of mutations and deregulated expression of
thyroid hormone receptors, altered expression and activ-
ity of iodothyronine deiodinases as well as decreased
intracellular concentrations of T3 in tumours. Whether
these changes play a causative role in the process of car-
cinogenesis is currently a matter of discussion. In vitro
studies in cancer cell lines and mouse models showed
that increased expression of DIO3 together with
enhanced proteasomal degradation of DIO2 in basal cell
carcinoma stimulates tumoral proliferation. Moreover, thyr-
oid hormone receptor beta-1 was shown to act as a power-
ful suppressor of tumour invasiveness and metastasis in
mouse models of breast cancer and hepatocarcinoma.
These studies suggest that local tissue hypothyroidism may
rather support tumoral transformation and even initiate
enhanced cancerous proliferation. In contrast, studies on
the effects of systemic hypothyroidism and cancer risk show
opposite or conflicting results. For instance, hypothyroidism
was associated with increased risk of hepatocellular carci-
noma, and cancers of lung and prostate. In case of breast
cancer, different studies reported that hypothyroidism was
linked to reduced risk of the disease in humans while when
studied in mice, hypothyroidism reduced tumour growth
but enhanced metastasis. Finally, studies performed on cell
line and mouse xenografts of thyroid and kidney cancers
showed that inhibition of integrin-mediated thyroid hor-
mone signaling can effectively result in inhibition of tumour
growth.
All these studies show that the role of thyroid hormones
in carcinogenic process is complex and presumably
depends on type of cancer and extra- or intracellular effects
of TH signaling. The results showing benefits from the use
of TH pathway genes in cancer treatment and diagnosis
suggest that further and more in depth studies are needed.
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